Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I.
[Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366
Doi: 10.1007/s00105-019-4359-y
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Woltsche Nora
- Co-authors Med Uni Graz
- El-Shabrawi-Caelen Laila
- Hofmann-Wellenhof Rainer
- Kränke Teresa Maria
- Kupsa Romana
- Zalaudek Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Eruptive epidermoid cysts are a rare adverse event of imiquimod treatment for basal cell carcinoma. Up to date, 8 cases have been described in the literature. We present the case of a 75-year-old Caucasian woman with recurrent basal cell carcinoma on the nose. After multiple excisions and treatment with vismodegib, imiquimod 5% cream was administered 5 times per week over 6 weeks. Two months after the end of treatment, the patient presented with eruptive epidermoid cysts.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aminoquinolines -
- Antineoplastic Agents - adverse effects
- Carcinoma, Basal Cell - drug therapy
- Epidermal Cyst - chemically induced
- Female -
- Humans -
- Imiquimod - adverse effects
- Skin Neoplasms - drug therapy
- Treatment Outcome -
- Find related publications in this database (Keywords)
- Adverse event
- Infundibular cysts
- Skin cancer
- Immunomodulators
- Excision